ClinVar Miner

Submissions for variant NM_032043.2(BRIP1):c.317G>A (p.Arg106His) (rs143615668)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131589 SCV000186601 likely benign Hereditary cancer-predisposing syndrome 2017-09-06 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence,In silico models in agreement (benign),Other strong data supporting benign classification
Color RCV000131589 SCV000910802 benign Hereditary cancer-predisposing syndrome 2015-09-23 criteria provided, single submitter clinical testing
Counsyl RCV000663050 SCV000786100 uncertain significance Fanconi anemia, complementation group J; Neoplasm of ovary 2018-02-21 criteria provided, single submitter clinical testing
GeneDx RCV000220020 SCV000278891 likely benign not specified 2017-12-06 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genetic Services Laboratory, University of Chicago RCV000220020 SCV000593769 likely benign not specified 2017-03-30 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000588637 SCV000699715 likely benign not provided 2017-05-26 criteria provided, single submitter clinical testing Variant summary: The BRIP1 c.317G>A (p.Arg106His) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 16/121406 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.001153 (12/10406). This frequency is about 18 times the estimated maximal expected allele frequency of a pathogenic BRIP1 variant (0.0000625), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. The variant has been reported in a 32 y.o. patient with colorectal cancer who also carries a known pathogenic APC variant (c.1759del/p.S587Afs*3, Pearlman_JAMAOnc_2016). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely benign (2) and VUS (1). Taken together, this variant is classified as likely benign.
Invitae RCV000197570 SCV000253628 likely benign Familial cancer of breast; Fanconi anemia, complementation group J 2018-01-03 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.